HTGMQ (HTG Molecular Diagnostics) Days Payable: 89.46 (As of Mar. 2023)

What is HTG Molecular Diagnostics Days Payable?

HTG Molecular Diagnostics HTGMQ 12 Days Payable is 89.46 as of Mar. 2023. GuruFocus rates HTGMQ with a GF Score™ of 12/100.

HTG Molecular Diagnostics's average Accounts Payable for the three months ended in Mar. 2023 was $1.13 Mil. HTG Molecular Diagnostics's Cost of Goods Sold for the three months ended in Mar. 2023 was $1.15 Mil. Hence, HTG Molecular Diagnostics's Days Payable for the three months ended in Mar. 2023 was 89.46.

The historical rank and industry rank for HTG Molecular Diagnostics's Days Payable or its related term are showing as below:

HTGMQ's Days Payable is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 67.275
* Ranked among companies with meaningful Days Payable only.

HTG Molecular Diagnostics's Days Payable declined from Mar. 2022 (158.27) to Mar. 2023 (89.46). It may suggest that HTG Molecular Diagnostics accelerated paying its suppliers.

HTG Molecular Diagnostics Days Payable Related Terms

HTG Molecular Diagnostics Days Payable Historical Data

* Premium members only.

The historical data trend for HTG Molecular Diagnostics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HTG Molecular Diagnostics Days Payable Chart

HTG Molecular Diagnostics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Payable

Get a 7-Day Free Trial

153.75

71.95

137.70

133.61

112.01

HTG Molecular Diagnostics Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Days Payable	Get a 7-Day Free Trial															158.27	109.50	124.36	41.94	89.46

HTGMQ vs ABMC, TMO, DHR: Days Payable Comparison

For the Diagnostics & Research subindustry, HTG Molecular Diagnostics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HTG Molecular Diagnostics Days Payable vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, HTG Molecular Diagnostics's Days Payable distribution charts can be found below:

* The bar in red indicates where HTG Molecular Diagnostics's Days Payable falls into.

Save Embed

12GF Score

HTG Molecular Diagnostics Inc HTGMQ

Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

HTG Molecular Diagnostics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

HTG Molecular Diagnostics's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

	Days Payable (A: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2021 )	+	Accounts Payable (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (1.649	+	1.157)	/	2 )	/	4.572	*	365
=	1.403					/	4.572	*	365
=	112.01

HTG Molecular Diagnostics's Days Payable for the quarter that ended in Mar. 2023 is calculated as:

	Days Payable (Q: Mar. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2022 )	+	Accounts Payable (Q: Mar. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2023 )	*	Days in Period
=	( (1.157	+	1.098)	/	2 )	/	1.15	*	365 / 4
=	1.1275					/	1.15	*	365 / 4
=	89.46

Frequently Asked Questions Learn more about Days Payable →

What does a Days Payable of 89.46 mean?

HTG Molecular Diagnostics (HTGMQ) has a Days Payable of 89.46 as of Mar. 2023. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on HTG Molecular Diagnostics and its competitors.

Is HTG Molecular Diagnostics' Days Payable too high?

HTG Molecular Diagnostics' current Days Payable is 89.46. The Medical Diagnostics & Research industry median Days Payable is 67.28. HTG Molecular Diagnostics' value of 89.46 is 33% above this industry median. Overall, HTG Molecular Diagnostics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.

How does HTG Molecular Diagnostics' Days Payable compare to ABMC and TMO?

HTG Molecular Diagnostics' Days Payable of 89.46 can be compared against companies in the Medical Diagnostics & Research industry. The industry median Days Payable is 67.28. HTG Molecular Diagnostics' value of 89.46 is 33% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Days Payable for a Medical Diagnostics & Research company?

The median Days Payable among Medical Diagnostics & Research companies is 67.28, based on 190 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HTG Molecular Diagnostics's current Days Payable of 89.46 is 33% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Days Payable mean?

A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on HTG Molecular Diagnostics and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 67.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HTG Molecular Diagnostics's current Days Payable is 89.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is HTG Molecular Diagnostics stock overvalued right now?

HTG Molecular Diagnostics (HTGMQ) has a current Days Payable of 89.46. The current Days Payable is 89.46 and 33% above the Medical Diagnostics & Research industry median of 67.28. HTG Molecular Diagnostics' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Days Payable calculated?

Days Payable is calculated from a company's financial statements. For HTG Molecular Diagnostics (HTGMQ), the current Days Payable is 89.46 as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HTG Molecular Diagnostics Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies ABMC TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN LH DGX WAT XPAR:BIM EXAS RVTY XPAR:ERF ASX:SHL CRL

Address 3430 E. Global Loop, Tucson, AZ, USA, 85706

Website https://www.htgmolecular.com

HTG Molecular Diagnostics Inc is a life science company whose mission is to advance precision medicine through its transcriptome-wide profiling and medicinal chemistry technologies. The company derives revenue from sales of its HTG EdgeSeq system and integrated next-generation sequencing-based HTG EdgeSeq research use only assays and from sample processing services performed in its VERI/O laboratory. The company operates in one segment and its customers and distributors are located in the United States and Europe.

12GF Score

Get the complete analysis for HTGMQ

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00

Price

View HTGMQ Analysis

See Days Payable data for all stocks →